Used in pharmaceutical research as a key intermediate in the synthesis of bioactive molecules targeting central nervous system disorders. Its structure supports the development of compounds with potential antipsychotic or antidepressant activity. The presence of trifluoromethyl and benzyl groups enhances metabolic stability and receptor binding affinity, making it valuable in optimizing drug candidates. Also employed in structure-activity relationship (SAR) studies to improve potency and selectivity of new therapeutic agents.